1425 - Hybrid SPECT/CT augmented lung perfusion scintigraphy for diagnosis of pulmonary thromboembolism: Assessment of superiority over conventional planar imaging and comparative evaluation of interpretation criteria (Modified PIOPED II and PISAPED). (ID 1107) - Society of Nuclear Medicine and Molecular Imaging 2019 Annual Meeting

1425 - Hybrid SPECT/CT augmented lung perfusion scintigraphy for diagnosis of pulmonary thromboembolism: Assessment of superiority over conventional planar imaging and comparative evaluation of interpretation criteria (Modified PIOPED II and PISAPED). (ID 1107)

Cardiovascular -> Clinical Science 1425

1425 - Hybrid SPECT/CT augmented lung perfusion scintigraphy for diagnosis of pulmonary thromboembolism: Assessment of superiority over conventional planar imaging and comparative evaluation of interpretation criteria (Modified PIOPED II and PISAPED). (ID 1107)

Session Name

Cardiovascular Clinical Science Posters

Speakers

H. Singh

Authors

Presentation Topic

Cardiovascular -> Clinical Science

Presentation Number

1425

Previous Eposter

1423 - Association of gastric wall tracer uptake with proton pump inhibitor use in patients undergoing ^99mTc-sestamibi myocardial perfusion scintigraphy (ID 1105)

Next Eposters

1428 - Reducing motion-correction variability in myocardial blood flow and reserve quantification (ID 1110)

1446 - Evaluation of coronary microvascular dysfunction in long-standing asymptomatic diabetic patients with ¹³N-NH₃ cardiac PET (ID 1128)

1458 - Relationship between amyloid deposition and cerebral glucose metabolism in cognitively normal elderly, patients with mild cognitive impairment and Alzheimer’s dementia (ID 1148)

1459 - A Novel Multi-Modality Molecular Imaging Index of Amyloid, Glucose Metabolism, and Morphologic Changes in the Brain for Evaluation of Patients with Dementia:A Thailand Perspective. (ID 1149)

1462 - In vivo imaging of Tau deposition using a new tracer-¹⁸F-S23 in comparison with ¹⁸F-THK5317 in Alzheimer’s disease (ID 1152)

1463 - Imaging of neurodegenerative diseases using Tau PET/CT with [¹¹C]PBB3 in a clinical setting (ID 1153)

1469 - Disrupted metabolic network in the cholinergic projection region in cognitive decline (ID 1159)

1470 - In vivo imaging of brain muscarinic receptors with ¹⁸F-Flurobenzyl Dexetimide: First in human studies (ID 1160)

1472 - Dual-model Radiomic biomarkers predict development of Mild Cognitive Impairment progression to Alzheimer’s disease (ID 1162)

1476 - Change of cerebral blood flow and glucose metabolism in patients with ischemic cerebrovascular disease (ID 1166)